Market Context — Why This Technology, Why Now

The global healthcare landscape is rapidly shifting towards data-driven diagnostics and personalized medicine, driven by increasing chronic disease burdens and technological advancements. Regulatory bodies are also encouraging objective endpoints in clinical trials. This technology directly addresses the critical need for quantitative biomarkers in dermatology, enabling more precise treatment, reducing subjective bias, and fostering competitive differentiation for companies entering the burgeoning remote patient monitoring and digital therapeutics markets.

Key Competitive Advantages
01

Improves Treatment Precision with Objective Assessment

02

Accelerates New Drug Development Trials

03

Strong, Unique, and Stable IP Protection

Market Opportunity
Pharmaceutical Industry
$3.5B globally (AI est.)
This technology could serve as an objective efficacy measurement in clinical trials for new pruritic disease drugs, contributing to shorter development times and higher success rates.
Global pharmaceutical R&D divisions Biotech companies developing dermatological drugs CROs specializing in clinical trials
Medical Device Manufacturers
$300M–$400M domestically (AI est.)
Commercializing this technology as a wearable scratching monitoring device could establish a new standard for diagnosis and treatment management in dermatology clinics and home healthcare settings.
Wearable medical device OEMs Dermatology diagnostic equipment providers Home healthcare technology developers
Digital Health and Telemedicine
$2B globally (AI est.)
Patients could monitor their pruritic condition at home and share data with physicians, enabling appropriate remote treatment guidance and QOL improvement programs.
Digital therapeutics platforms Remote patient monitoring solution providers Health data analytics companies
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a detection sensor and evaluation system capable of stably and accurately measuring the frequency and intensity of human scratching behavior, comprising 5 robust claims. Its novelty and inventiveness were highly recognized by the examiner, with only three prior art documents cited, indicating strong uniqueness and technical superiority that could deter competitors.

Competitive White Space

This patent focuses on the core scratching detection mechanism. White space exists in integrating this data with other physiological biomarkers (e.g., sleep patterns, stress levels) or developing AI-driven predictive analytics for itch flare-ups.

Economic Impact
~$2M/year estimated healthcare and development cost reduction (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Optimizing drug selection and reducing inappropriate medication for pruritic diseases. For example, if unnecessary medical costs are reduced by ~$20/person (AI est.) annually for 100,000 patients through appropriate treatment, an annual healthcare cost reduction of ~$2M (AI est.) is projected. Additionally, pharmaceutical companies could achieve development cost reductions by shortening trial periods and improving success rates when adopting this technology for new drug development.

Speed to Market
6× faster than in-house development
This technology, a research outcome from a national university corporation, has established the basic principles of scratching detection and sensor configuration. Strain gauges are general-purpose sensors, and their detection logic is clear, eliminating the need for licensees to conduct R&D from scratch. By adopting this patent, companies could significantly reduce the approximately 3 years required for in-house development to about 0.5 years, by focusing on integration into existing technical platforms and product optimization.
Competitive Positioning

X: Objectivity & Quantitative Assessment
Y: Ease of Integration & Cost Performance

Business Models & Applications
⌚ Device Sales
Directly sell the scratching detection sensor to medical institutions and patients, aiming for initial revenue and continuous income from consumables. This targets entry into the wearable device market.
📊 Data Analysis Service
A SaaS model offering reports on disease progression and treatment efficacy by analyzing detected scratching behavior data. Also considers providing data to pharmaceutical companies and research institutions.
🤝 Technology Licensing
License this patent to medical device manufacturers and digital health companies to generate royalty income. This model enables broad market expansion.
Adjacent Application Opportunities
🏃 Sports & Rehabilitation
Precision Movement Pattern Analysis
Applying the scratching detection principle, this technology could analyze subtle forms in athletes or quantitatively assess joint movements in rehabilitation patients. High-precision motion data could optimize training and treatment plans.
👶 Childcare & Elderly Care
Unconscious Behavior Monitoring
Could be used in monitoring devices to detect scratching in infants due to discomfort or subtle body movements in the elderly that indicate a fall risk. Early anomaly detection could prevent accidents and provide peace of mind.
🧠 Mental Health
Stress-Induced Behavior Visualization
By detecting unconscious scratching or repetitive movements caused by stress or anxiety, this tool could objectively assess mental health states. This has the potential to contribute to early intervention and improved quality of care.
Integration Roadmap — Estimated 22-Month Deployment
Phase 1: Technology Evaluation & Prototype Optimization
Duration: 4 months
Evaluates the core scratching detection sensor's performance and its compatibility with the licensee's existing systems. Focuses on design optimization for miniaturization and enhanced durability of the prototype.
Phase 2: Product Development & Clinical Validation
Duration: 10 months
Develops a mass-producible product design and data analysis algorithms based on the optimized prototype. Concurrently, conducts clinical validation with medical institutions to verify efficacy and safety.
Phase 3: Market Launch & Mass Production Setup
Duration: 8 months
Obtains product certifications and establishes a mass production system in collaboration with manufacturing partners. Launches the product as a medical or wellness device, establishing sales channels for business expansion.
Technical Feasibility
The scratching behavior detection sensor, with its simple claw and ring member structure and general-purpose strain gauge, is relatively easy to integrate into existing wearable devices and IoT platforms. The patent claims clearly describe its components and detection principles, indicating high technical feasibility. Product commercialization could proceed without extensive new dedicated equipment, leveraging existing manufacturing processes and development resources.
Success Scenario
Adopting this technology could enable companies to introduce new diagnostic and monitoring devices for dermatology. Patients could objectively track their itch at home, and physicians could determine optimal treatment plans based on data. This is estimated to significantly improve the quality of life for pruritic disease patients, increase new drug trial success rates by 20%, and shorten development periods by an average of 6 months.
Patent Record
APPLICATION NO.
特願2021-028556
REGISTRATION NO.
7525164
FILING DATE
2021/02/25
GRANT DATE
2024/07/22
EXPIRATION DATE
2041/02/25
PATENT HOLDER
国立大学法人　長崎大学
Examination History
2023年12月04日
出願審査請求書
2024年07月09日
特許査定